Skip to main content
Top

Familial Cancer

Issue 2/2001

Content (11 Articles)

Familial breast cancer: an investigation into the outcome of treatment for early stage disease

Diana Eccles, Peter Simmonds, Jonathan Goddard, Marie Coultas, Shirley Hodgson, Fiona Lalloo, Gareth Evans, Neva Haites

Familial adenomatous polyposis at the Tel Aviv Medical Center: demographic and clinical features

Paul Rozen, Ziona Samuel, Micha Rabau, Gideon Goldman, Ruth Shomrat, Cyril Legum, Avi Orr-Urtreger

The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) – Results of an international collaborative study

Wolfram Müller, Lawrence J. Burgart, Ruth Krause-Paulus, Stephen N. Thibodeau, M. Almeida, T. Brocker Edmonston, C. R. Boland, C. Sutter, J. R. Jass, A. Lindblom, J. Lubinski, K. MacDermot, D. S. A. Sanders, H. Morreau, A. Müller, C. Oliani, T. Orntoft, M. Ponz De Leon, C. Rosty, M. Rodriguez-Bigas, J. Rüschoff, A. Ruszkiewicz, J. Sabourin, R. Salovaara, Gabriela Möslein

Mutations of the 'minor' mismatch repair gene MSH6 in typical and atypical hereditary nonpolyposis colorectal cancer

Emanuela Lucci-Cordisco, Valentina Rovella, Stefania Carrara, Antonio Percesepe, Monica Pedroni, Alfonso Bellacosa, Oana Caluseriu, Mara Forasarig, Marcello Anti, Giovanni Neri, Maurizio Ponz de Leon, Alessandra Viel, Maurizio Genuardi

Café-au-lait spots and early onset colorectal neoplasia: a variant of HNPCC?

Jill D. Trimbath, Gloria M. Petersen, Steven H. Erdman, Merry Ferre, Michael C. Luce, Francis M. Giardiello

Chemotherapy resistant ovarian cancer in carriers of an hMSH2 mutation?

C. L. M. Marcelis, H. W. H. M. van der Putten, C. Tops, L. C. H. W. Lutgens, U. Moog

Preventive measures in Peutz-Jeghers syndrome

Daniel R. McGrath, Allan D. Spigelman

Instructions for Authors

Instructions for authors

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine